Cargando…

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions

OBJECTIVE: Unplanned 30‐day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sara, Adams, William, Bier‐Laning, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242425/
https://www.ncbi.nlm.nih.gov/pubmed/35782404
http://dx.doi.org/10.1002/wjo2.56
_version_ 1784738054360006656
author Yang, Sara
Adams, William
Bier‐Laning, Carol
author_facet Yang, Sara
Adams, William
Bier‐Laning, Carol
author_sort Yang, Sara
collection PubMed
description OBJECTIVE: Unplanned 30‐day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled nursing facilities, and appropriate use of patient observation status. METHODS: This was a quality improvement study of all unplanned admissions to the Head and Neck Oncology service at a tertiary care facility during a 3‐year period between October 2015 and September 2018. In October 2016, when the Head and Neck Oncology service revised its discharge practices for patients undergoing extirpative and/or reconstructive surgery. These changes included enhancing patient education, increasing the use of a skilled nursing facility with directed staff education and patient handoffs by advanced practice nurses, and appropriate utilization of 23‐h observation status for returning patients. The readmission rate from the pre‐intervention era (October 2015 through September 2016) was compared to the readmission rate from the post‐intervention era (October 2016 through September 2018). Secondary outcomes were the rates of 23‐h observation within 30 days of the discharge as well as emergency room visits within 30 days of discharge. RESULTS: In this sample of 449 patients, 161 (35.9%) were observed before the change‐in‐practice (before October 2016), and 288 (64.1%) were observed following the change‐in‐practice (after September 2016). On univariable analysis, the risk of readmission declined by approximately 41.4% from the pre‐intervention era, though this conclusion was not statistically significant (P = 0.06). On multivariable analysis, patients at moderate or high risk of death were 2.31 times more likely than those at minor risk of death to readmit within 30 days (P = 0.03). Similarly, those with recurrent or persistent cancer were 3.33 times more likely than those undergoing initial curative surgical management of cancer to readmit within 30 days (P = 0.001). No patient characteristics were associated with a 23‐h observation following discharge (all P > 0.05). Conclusions were similar for emergency room visits following discharge. CONCLUSIONS: A three‐part quality improvement strategy resulted in a clinically important decrease in 30‐day readmissions, though the decline was not statistically significant. There were no significant changes in 23‐h observation within 30 days of discharge or emergency room visits within 30 days of discharge.
format Online
Article
Text
id pubmed-9242425
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92424252022-07-01 Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions Yang, Sara Adams, William Bier‐Laning, Carol World J Otorhinolaryngol Head Neck Surg Research Papers OBJECTIVE: Unplanned 30‐day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled nursing facilities, and appropriate use of patient observation status. METHODS: This was a quality improvement study of all unplanned admissions to the Head and Neck Oncology service at a tertiary care facility during a 3‐year period between October 2015 and September 2018. In October 2016, when the Head and Neck Oncology service revised its discharge practices for patients undergoing extirpative and/or reconstructive surgery. These changes included enhancing patient education, increasing the use of a skilled nursing facility with directed staff education and patient handoffs by advanced practice nurses, and appropriate utilization of 23‐h observation status for returning patients. The readmission rate from the pre‐intervention era (October 2015 through September 2016) was compared to the readmission rate from the post‐intervention era (October 2016 through September 2018). Secondary outcomes were the rates of 23‐h observation within 30 days of the discharge as well as emergency room visits within 30 days of discharge. RESULTS: In this sample of 449 patients, 161 (35.9%) were observed before the change‐in‐practice (before October 2016), and 288 (64.1%) were observed following the change‐in‐practice (after September 2016). On univariable analysis, the risk of readmission declined by approximately 41.4% from the pre‐intervention era, though this conclusion was not statistically significant (P = 0.06). On multivariable analysis, patients at moderate or high risk of death were 2.31 times more likely than those at minor risk of death to readmit within 30 days (P = 0.03). Similarly, those with recurrent or persistent cancer were 3.33 times more likely than those undergoing initial curative surgical management of cancer to readmit within 30 days (P = 0.001). No patient characteristics were associated with a 23‐h observation following discharge (all P > 0.05). Conclusions were similar for emergency room visits following discharge. CONCLUSIONS: A three‐part quality improvement strategy resulted in a clinically important decrease in 30‐day readmissions, though the decline was not statistically significant. There were no significant changes in 23‐h observation within 30 days of discharge or emergency room visits within 30 days of discharge. John Wiley and Sons Inc. 2022-05-02 /pmc/articles/PMC9242425/ /pubmed/35782404 http://dx.doi.org/10.1002/wjo2.56 Text en © 2022 The Authors. World Journal of Otorhinolaryngology ‐ Head and Neck Surgery published by John Wiley & Sons Ltd on behalf of Chinese Medical Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Papers
Yang, Sara
Adams, William
Bier‐Laning, Carol
Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title_full Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title_fullStr Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title_full_unstemmed Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title_short Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
title_sort head and neck cancer readmission reduction (hancarre) project: reducing 30‐day readmissions
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242425/
https://www.ncbi.nlm.nih.gov/pubmed/35782404
http://dx.doi.org/10.1002/wjo2.56
work_keys_str_mv AT yangsara headandneckcancerreadmissionreductionhancarreprojectreducing30dayreadmissions
AT adamswilliam headandneckcancerreadmissionreductionhancarreprojectreducing30dayreadmissions
AT bierlaningcarol headandneckcancerreadmissionreductionhancarreprojectreducing30dayreadmissions